I'd say data are stellar for G551D mutation carriers, and there's still hope for the F508del mutation carriers that the VX-809/VX-770 combo therapy will work with acceptable safety profile.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.